News

Dr. Guy Sauvageau elected to the Academy of Science of the Royal Society of Canada

  Montreal, September 11, 2018– Dr. Guy Sauvageau, Principal Investigator at the Institute for Research in Immunology and Cancer (IRIC) of the Université de Montréal and hematologist at the Maisonneuve-Rosemont Hospital (CIUSSS de l’Est-de-l’Île-de-Montréal), has been elected a member of the Academy of Science of the Royal Society of Canada (RSC).   A multidisciplinary commitment […]

The Montreal Alouettes: proud IRIC supporters and donors

The Montreal Alouettes support the Institute for Research in Immunology and Cancer (IRIC) of the Université de Montréal through its Matching Gifts Program. The Alouettes’ organization agrees to match each individual donation made to the Institute, thus doubling the impact of the donations received. The IRIC also wishes to recognize the Montreal Alouettes’ energy and benevolence, […]

CIHR announcement

On August 13th 2018, an announcement was held at the Agora, in the presence of the Honourable Ginette Petitpas Taylor – Minister of Health, to highlight the work of the Canadian Institutes of Health Research (CIHR) recipients.    Kathy Borden and Marc Therrien each received a grant from the CIHR, as part of the 2018 Project Grant Spring competition […]

IRICoR receives 25 million dollars to support its research commercialization activities as part of the 2018 CECR competition

Montreal, July 30, 2018 — IRICoR (Institute for Research in Immunology and Cancer – Commercialization of Research), a drug discovery and commercialization cluster, is proud to announce that it has received substantial support from the federal government in the amount of 25 million dollars, as part of the 2018 edition of the Centres of Excellence […]

Two IRIC investigators receive a grant from the Canadian Institutes of Health Research

Kathy Borden and Marc Therrien each recently received a grant from the Canadian Institutes of Health Research (CIHR), respectively as part of the Project Grant: Spring 2018 competition and the Foundation Grant: 2017-2018 competition. Kathy Borden, Principal Investigator, Structure and Function of the Cell Nucleus research unit at the IRIC and Full Professor, Department of […]

Appointment of Robert Paré and renewal of Jacques Bernier’s mandate on the IRIC’s Board of Directors

The IRIC is pleased to announce the appointment of Mtre Robert Paré as a new member of the Board of Directors as well as the renewal of Mr. Jacques Bernier’s mandate as a member of the Board by the Executive Committee of the Université de Montréal. Mtre Robert Paré, Strategic Advisor with Fasken, has been […]

Renewal of Michel Bouvier’s mandate as Chief Executive Officer of the IRIC

Following a meeting of the Executive Committee, held on June 12, the Université de Montréal announced the continuation of Michel Bouvier’s mandate as Chief Executive Officer of the IRIC for a second four-year term. Mr. Bouvier is a Full Professor in the Department of Biochemistry and Molecular Medicine of the Université de Montréal’s Faculty of […]

Thanks to the Blais Family Fund Golf Tournament, $70 000 was raised to support the research against cancer at the IRIC

More than 144 golfers gathered at the Buckingham Golf Club on July 6th for the Blais Family Fund Golf Tournament. $70 000 was raised to support the research against cancer at the IRIC. Pierre Blais, founder of the Blais Family Fund Golf Tournament, survived cancer thanks to an innovative procedure suggested by Dr. Sauvageau, Principal Investigator […]

UM171 Molecule: Completion of Phase I/II clinical trial for the treatment of blood cancer patients

On June 12, the Institute for Research in Immunology and Cancer (IRIC) of the Université de Montréal celebrated 10 years of activity for its medicinal chemistry core facility, the largest of its kind in a university setting in Canada. Today, the IRIC announces the completion of Phase I/II of the clinical trial testing the efficacy […]

Next Page »

Follow IRIC

Logo UdeM